Evidence map›Paper›PMID 38809496›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2024

ST88 ceftazidime-resistant Stenotrophomonas maltophilia is present in the saliva and gingival crevicular fluid of patients with periodontitis and AIDS from São Paulo State, Brazil.

Felipe Pinheiro Vilela, Amanda Akemi Kakumoto, Carolina Nogueira Gomes, Tábata Larissa Santos Pólvora, Átila Vinícius Vítor Nobre, Alan Grupioni Lourenço, Ana Carolina Fragoso Motta, Juliana Pfrimer Falcão

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Felipe Pinheiro VilelaFaculdade de Ciências Farmacêuticas de Ribeirão Preto- USP, Departmento de Análises Clínicas, Toxicológicas e Bromatológicas, Av. do Café, s/n, Bloco S- Sala 41, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-7506-6181
Amanda Akemi KakumotoFaculdade de Odontologia de Ribeirão Preto- USP, Departmento de Estomatologia, Saúde Pública e Odontologia Legal, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0001-7929-1215
Carolina Nogueira GomesFaculdade de Ciências Farmacêuticas de Ribeirão Preto- USP, Departmento de Análises Clínicas, Toxicológicas e Bromatológicas, Av. do Café, s/n, Bloco S- Sala 41, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0003-2914-4107
Tábata Larissa Santos PólvoraFaculdade de Odontologia de Ribeirão Preto- USP, Departmento de Estomatologia, Saúde Pública e Odontologia Legal, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0001-6284-4143
Átila Vinícius Vítor NobreFaculdade de Odontologia de Ribeirão Preto- USP, Departmento de Estomatologia, Saúde Pública e Odontologia Legal, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-5416-3994
Alan Grupioni LourençoFaculdade de Odontologia de Ribeirão Preto- USP, Departmento de Estomatologia, Saúde Pública e Odontologia Legal, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-4005-157X
Ana Carolina Fragoso MottaFaculdade de Odontologia de Ribeirão Preto- USP, Departmento de Estomatologia, Saúde Pública e Odontologia Legal, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-3887-9239
Juliana Pfrimer FalcãoFaculdade de Ciências Farmacêuticas de Ribeirão Preto- USP, Departmento de Análises Clínicas, Toxicológicas e Bromatológicas, Av. do Café, s/n, Bloco S- Sala 41, Ribeirão Preto, SP, Brazil. jufalcao@fcfrp.usp.br.ORCID http://orcid.org/0000-0002-1459-9355

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 303475/2015-3; 304399/2018-3; 304803/2021-9Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance Code 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/24716-3; 2019/19338-8; 2022/07013-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/05756-7; 2019/06947-6; 2021/07365-0
6 · The paper itself

Abstract

Stenotrophomonas maltophilia (S. maltophilia) is an intrinsically drug-resistant and biofilm-forming bacteria causing infections in immunocompromised humans. This study reports the isolation of five S. maltophilia strains from saliva and gingival crevicular fluid (GCF) of AIDS patients with periodontitis in São Paulo, Brazil, showing resistance to ceftazidime, strong biofilm formation capacity and a close genetic relationship. The presence of S. maltophilia strains in saliva and CGF of patients with AIDS and periodontitis is a concern for the presence and persistence of intrinsically resistant bacteria in the oral environment, enhancing the risk for the development of severe infections in immunocompromised patients.

Indexed as

Acquired Immunodeficiency SyndromeAnti-Bacterial AgentsBiofilmsCeftazidimeGingival Crevicular FluidGram-Negative Bacterial InfectionsPeriodontitisSalivaStenotrophomonas maltophiliaAdultBrazilDrug Resistance, BacterialFemaleHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsCeftazidimeAntibiotic resistanceHIVMolecular typing; biofilmsStenotrophomonas maltophilia

Identifiers

PMID38809496
PMCPMC11405574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.